A single-arm, phase II trial of neoadjuvant gemcitabine and S1 in patients with resectable and borderline resectable pancreatic adenocarcinoma: PREP-01 study

被引:0
作者
Fuyuhiko Motoi
Sohei Satoi
Goro Honda
Keita Wada
Hiroyuki Shinchi
Ippei Matsumoto
Masayuki Sho
Akihiko Tsuchida
Michiaki Unno
机构
[1] Tohoku University Graduate School of Medicine,Department of Surgery
[2] Kansai Medical University,Department of Surgery
[3] Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital,Department of Surgery
[4] Teikyo University School of Medicine,Department of Surgery
[5] Kagoshima University,Department of Digestive Surgery, Breast and Thyroid Surgery
[6] Kindai University Faculty of Medicine,Department of Surgery
[7] Nara Medical University,Department of Surgery
[8] Tokyo Medical University,Department of Gastrointestinal and Pediatric Surgery
来源
Journal of Gastroenterology | 2019年 / 54卷
关键词
Neoadjuvant; Chemotherapy; Pancreatic cancer; Surgery;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:194 / 203
页数:9
相关论文
共 84 条
[1]  
Siegel RL(2017)Cancer statistics, 2017 CA Cancer J Clin 67 7-30
[2]  
Miller KD(2017)Current standards of chemotherapy for pancreatic cancer Clin Ther 39 2125-2134
[3]  
Jemal A(2007)National failure to operate on early stage pancreatic cancer Ann Surg 246 173-180
[4]  
Saung MT(2012)Survival after resection of pancreatic adenocarcinoma: results from a single institution over three decades Ann Surg Oncol 19 169-175
[5]  
Zheng L(2004)A randomized trial of chemoradiotherapy and chemotherapy after resection of pancreatic cancer N Engl J Med 351 1200-1210
[6]  
Bilimoria KY(2013)Adjuvant chemotherapy with gemcitabine and long-term outcomes among patients with resected pancreatic cancer: the CONKO-001 randomized trial JAMA 310 1473-1481
[7]  
Bentrem DJ(2012)Effect of adjuvant chemotherapy with fluorouracil plus folinic acid or gemcitabine vs observation on survival in patients with resected periampullary adenocarcinoma: the ESPAC-3 periampullary cancer randomized trial JAMA 308 147-156
[8]  
Ko CY(2016)Adjuvant chemotherapy of S-1 versus gemcitabine for resected pancreatic cancer: a phase 3, open-label, randomised, non-inferiority trial (JASPAC 01) Lancet 388 248-257
[9]  
Winter JM(2017)Comparison of adjuvant gemcitabine and capecitabine with gemcitabine monotherapy in patients with resected pancreatic cancer (ESPAC-4): a multicentre, open-label, randomised, phase 3 trial Lancet 389 1011-1024
[10]  
Brennan MF(1998)The role of diagnostic laparoscopy in pancreatic and periampullary malignancies J Am Coll Surg 186 675-682